APA (7th ed.) Citation

Cariou, B., Hanf, R., Lambert-Porcheron, S., Zaïr, Y., Sauvinet, V., Noël, B., . . . Laville, M. (2013). Dual Peroxisome Proliferator–Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects. Diabetes care, 36(10), 2923-2930. https://doi.org/10.2337/dc12-2012

Chicago Style (17th ed.) Citation

Cariou, Bertrand, et al. "Dual Peroxisome Proliferator–Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects." Diabetes Care 36, no. 10 (2013): 2923-2930. https://doi.org/10.2337/dc12-2012.

MLA (9th ed.) Citation

Cariou, Bertrand, et al. "Dual Peroxisome Proliferator–Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects." Diabetes Care, vol. 36, no. 10, 2013, pp. 2923-2930, https://doi.org/10.2337/dc12-2012.